
| Salt Composition: | Ceftriaxone (250mg) + Sulbactam (125mg) |
| Manufacturer: | Overseas Healthcare Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Mat CS 250 mg/125 mg Injection is a combination medicine used to treat various types of bacterial infections. It fights against microorganisms to prevent their growth and further spread of the infection. Mat CS 250 mg/125 mg Injection should only be administered under the supervision of a healthcare professional. Do not miss any scheduled appointments for taking this medicine. The course of the treatment must be completed even if you feel better. Sudden discontinuation of the treatment may affect the potency of the medicine. Some common side effects of this medicine are nausea, vomiting, diarrhea, indigestion, etc. If any of the side effects get aggravated, you must consult your doctor immediately. If you experience any allergic reaction (rashes, itching, swelling, shortness of breath, etc.), you must seek immediate medical help. Before taking this medicine, you should tell your doctor if you are taking any medicines for any health condition. Pregnant or breastfeeding women should also consult with their doctor before taking it. Avoid drinking alcohol as it can cause excessive drowsiness with this medicine. It usually does not impair your ability to drive, but you should not drive if it makes you feel sleepy or dizzy. You must take adequate rest for a faster recovery, also take a healthy diet and drink plenty of water. Your doctor may ask for a few laboratory and diagnostic tests to know the effects of the medicine on your body.
Mat CS 250 mg/125 mg Injection is a combination of two medicines: Ceftriaxone and Sulbactam. Ceftriaxone is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Sulbactam is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Ceftriaxone against bacteria.
What are the possible allergic reactions associated with using Mat CS 250 mg/125 mg Injection?
Mat CS 250 mg/125 mg Injection can cause an allergic reaction, which may manifest as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat. If you experience any of these symptoms, seek immediate medical attention.
Can Mat CS 250 mg/125 mg Injection lead to gastrointestinal issues?
Yes, this medication can cause diarrhea as it disrupts the balance of good bacteria in your stomach or intestine, which may be severe in some cases. If you experience persistent or severe diarrhea, consult with your doctor for guidance.
How long does Mat CS 250 mg/125 mg Injection typically take to produce noticeable effects?
The onset of action for Mat CS 250 mg/125 mg Injection usually occurs shortly after administration. However, it may require several days to eliminate the infection and alleviate symptoms completely.
What should I do if my symptoms persist or worsen while using Mat CS 250 mg/125 mg Injection?
If you do not experience significant improvement in your condition after completing the full treatment course, inform your doctor. Additionally, report any worsening symptoms to them for further evaluation and guidance.
Can I stop taking Mat CS 250 mg/125 mg Injection once my symptoms improve?
No, it is essential to complete the entire prescribed treatment duration even if you feel better. Stopping too soon may allow the infection to persist or recur.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Alcohol
Consuming alcohol with Mat CS 250 mg/125 mg Injection does not cause any harmful side effects.
Breastfeed
Mat CS 250 mg/125 mg Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Pregnancy
Mat CS 250 mg/125 mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.